[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2003249812A1 - Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents - Google Patents

Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents

Info

Publication number
AU2003249812A1
AU2003249812A1 AU2003249812A AU2003249812A AU2003249812A1 AU 2003249812 A1 AU2003249812 A1 AU 2003249812A1 AU 2003249812 A AU2003249812 A AU 2003249812A AU 2003249812 A AU2003249812 A AU 2003249812A AU 2003249812 A1 AU2003249812 A1 AU 2003249812A1
Authority
AU
Australia
Prior art keywords
ictogenic
dihydrouracil
compounds
epileptogenic agents
epileptogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003249812A
Other versions
AU2003249812A8 (en
Inventor
Kathryn A. Jones
Kathryn E. Tiedje
Donald F. Weaver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University at Kingston
Original Assignee
Queens University at Kingston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens University at Kingston filed Critical Queens University at Kingston
Publication of AU2003249812A1 publication Critical patent/AU2003249812A1/en
Publication of AU2003249812A8 publication Critical patent/AU2003249812A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003249812A 2002-07-18 2003-07-18 Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents Abandoned AU2003249812A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39715702P 2002-07-18 2002-07-18
US60/397,157 2002-07-18
PCT/CA2003/001082 WO2004009559A2 (en) 2002-07-18 2003-07-18 Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents

Publications (2)

Publication Number Publication Date
AU2003249812A1 true AU2003249812A1 (en) 2004-02-09
AU2003249812A8 AU2003249812A8 (en) 2004-02-09

Family

ID=30771012

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003249812A Abandoned AU2003249812A1 (en) 2002-07-18 2003-07-18 Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents

Country Status (2)

Country Link
AU (1) AU2003249812A1 (en)
WO (1) WO2004009559A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008106128A2 (en) 2007-02-26 2008-09-04 Vitae Pharmaceuticals, Inc. CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
WO2009017671A1 (en) 2007-07-26 2009-02-05 Vitae Pharmaceuticals, Inc. Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
AR069207A1 (en) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc CYCLIC UREAS AS INHIBITORS OF THE 11 BETA - HIDROXI-ESTEROIDE DESHIDROGENASA 1
EP2229368A1 (en) 2007-12-11 2010-09-22 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2252598A2 (en) 2008-02-11 2010-11-24 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5730021B2 (en) 2008-02-15 2015-06-03 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Cycloalkyllactam derivatives as inhibitors of 11β-hydroxysteroid dehydrogenase 1
AU2009241727B2 (en) 2008-05-01 2013-05-02 Vitae Pharmaceuticals, Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291373B1 (en) 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134392A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CN104327062A (en) 2008-07-25 2015-02-04 贝林格尔·英格海姆国际有限公司 Cyclic Inhibitors of 11Beta-Hydroxysteroid Dehydrogenase 1
US8846668B2 (en) 2008-07-25 2014-09-30 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5860042B2 (en) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Substituted 5, 6 and 7 membered heterocycles, medicaments containing such compounds and their use
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
CA2813671A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
WO2014107622A1 (en) 2013-01-07 2014-07-10 University Of Southern California Deoxyuridine triphosphatase inhibitors
WO2017006270A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors
AU2016290987C1 (en) 2015-07-08 2023-07-20 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2017006271A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
US10544105B2 (en) 2015-07-08 2020-01-28 Cv6 Therapeutics (Ni) Limited Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
US11014924B2 (en) 2016-11-23 2021-05-25 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2018098206A1 (en) 2016-11-23 2018-05-31 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2018098204A1 (en) 2016-11-23 2018-05-31 Cv6 Therapeutics (Ni) Limited 6-membered uracil isosteres
US10829457B2 (en) 2016-11-23 2020-11-10 Cv6 Therapeutics (Ni) Limited Nitrogen ring linked deoxyuridine triphosphatase inhibitors
US11168059B2 (en) 2016-11-23 2021-11-09 Cv6 Therapeutics (Ni) Limited Amino sulfonyl compounds
WO2018128720A1 (en) * 2017-01-05 2018-07-12 Cv6 Therapeutics (Ni) Limited Uracil containing compounds
WO2018220762A1 (en) 2017-05-31 2018-12-06 大塚製薬株式会社 Pyrimidine compound
JP6870064B2 (en) * 2018-11-30 2021-05-12 大塚製薬株式会社 Pharmaceutical use of pyrimidine compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243017A (en) * 1984-05-16 1985-12-03 Kyowa Hakko Kogyo Co Ltd Antispasmodic composition
JPS61236724A (en) * 1985-04-13 1986-10-22 Kyowa Hakko Kogyo Co Ltd Antispasmodic composition
WO2002083651A2 (en) * 2001-04-11 2002-10-24 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents

Also Published As

Publication number Publication date
WO2004009559A3 (en) 2004-04-01
WO2004009559A2 (en) 2004-01-29
AU2003249812A8 (en) 2004-02-09

Similar Documents

Publication Publication Date Title
AU2003249812A1 (en) Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents
AU2003273017A1 (en) Water-and-oil repellant composition
GB0213638D0 (en) Composition
AU2002952384A0 (en) Structures
AU2003285288A1 (en) Composition
AU2003301654A1 (en) Stabilized composition
GB0204712D0 (en) Long acting parasiticidal composition
AU2002950744A0 (en) Composition
GB0203421D0 (en) Composition
AU2003235708A1 (en) Polytartrate composition
AU2003230395A1 (en) Micro-support structures
AU2003299100A1 (en) Pyrimidine compounds as therapeutic agents
GB0208608D0 (en) Composition
AU2003208411A1 (en) Anti-glycolytic composition
AU2003269904A1 (en) Antigen-polymer compositions
AU2003290818A1 (en) Topoisomerase-targeting agents
AU2003297381A1 (en) Attachment means
GB0211924D0 (en) Composition
GB0218241D0 (en) Composition
AU2003100144A4 (en) Lousicide composition
AU2003208841A1 (en) Gasolinen compositions
EP1495751A4 (en) Hairdye composition
AU2003268772A1 (en) Oil-barrier composition
AU2003216382A1 (en) Idothyronine compositions
AU2003285827A1 (en) Biopesticide composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase